Iterum Therapeutics Receives Complete Response Letter from U.S. Food and Drug Administration for Oral Sulopenem Jul 26, 2021
Iterum Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on May 14, 2021 May 7, 2021
Iterum Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 12, 2021 Mar 5, 2021
